A L Hunter

622 total citations
9 papers, 529 citations indexed

About

A L Hunter is a scholar working on Oncology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, A L Hunter has authored 9 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in A L Hunter's work include Drug Transport and Resistance Mechanisms (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). A L Hunter is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). A L Hunter collaborates with scholars based in United States. A L Hunter's co-authors include Robert A. Neal, Myron A. Holscher, Curtis D. Klaassen, Elizabeth A. Thomas, Michael T. Griffin, Frederick J. Ehlert and C D Klaassen and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Molecular Pharmacology.

In The Last Decade

A L Hunter

9 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A L Hunter United States	6	272	156	105	79	75	9	529
Jacqueline Loeper France	13	362 1.3×	195 1.3×	146 1.4×	104 1.3×	92 1.2×	18	677
Philip Wiebkin United Kingdom	13	210 0.8×	135 0.9×	99 0.9×	42 0.5×	54 0.7×	23	503
Jean‐Paul Leroux France	14	326 1.2×	203 1.3×	127 1.2×	50 0.6×	14 0.2×	24	685
Sam A. Bruschi United States	14	220 0.8×	268 1.7×	106 1.0×	42 0.5×	80 1.1×	22	634
Leslie R. Schwarz Germany	11	147 0.5×	149 1.0×	374 3.6×	89 1.1×	55 0.7×	22	638
Antoine Vercruysse Belgium	16	213 0.8×	270 1.7×	93 0.9×	29 0.4×	170 2.3×	38	631
Ryuichi Kato Japan	10	182 0.7×	281 1.8×	76 0.7×	32 0.4×	26 0.3×	15	633
Catherine Viollon‐Abadie France	12	225 0.8×	214 1.4×	151 1.4×	55 0.7×	207 2.8×	14	688
Urmila M. Joshi United States	11	112 0.4×	139 0.9×	40 0.4×	35 0.4×	56 0.7×	15	422
Kai E. Penttilä Finland	14	346 1.3×	225 1.4×	148 1.4×	218 2.8×	172 2.3×	21	892

Countries citing papers authored by A L Hunter

Since Specialization

Citations

This map shows the geographic impact of A L Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A L Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A L Hunter more than expected).

Fields of papers citing papers by A L Hunter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A L Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A L Hunter. The network helps show where A L Hunter may publish in the future.

Co-authorship network of co-authors of A L Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of A L Hunter. A scholar is included among the top collaborators of A L Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A L Hunter. A L Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Thomas, Elizabeth A., et al.. (1992). Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.. Molecular Pharmacology. 41(4). 718–726. 43 indexed citations

2.

Hunter, A L, et al.. (1987). Metabolism and distribution of 14C- and 35S-labeled carbon disulfide in immature rats of different ages.. Drug Metabolism and Disposition. 15(3). 289–294. 1 indexed citations

3.

Hunter, A L, et al.. (1985). Toxicity of carbon disulfide in developing rats: LD50 values and effects on the hepatic mixed-function oxidase enzyme system. Toxicology and Applied Pharmacology. 78(1). 130–138. 3 indexed citations

4.

Hunter, A L, Myron A. Holscher, & Robert A. Neal. (1977). Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system.. Journal of Pharmacology and Experimental Therapeutics. 200(2). 439–448. 180 indexed citations

5.

Hunter, A L & Curtis D. Klaassen. (1975). Biliary excretion of colchicine.. Journal of Pharmacology and Experimental Therapeutics. 192(3). 605–617. 75 indexed citations

6.

Hunter, A L & Robert A. Neal. (1975). Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds. Biochemical Pharmacology. 24(23). 2199–2205. 149 indexed citations

7.

Hunter, A L, et al.. (1975). Toxicological implications op the mixed-function oxidase catalyzed metabolism of carbon disulfide. Chemico-Biological Interactions. 10(5). 349–361. 69 indexed citations

8.

Hunter, A L & Curtis D. Klaassen. (1975). BILIARY EXCRETION OF COLCHICINE IN NEWBORN RATS. Drug Metabolism and Disposition. 3(6). 530–535. 3 indexed citations

9.

Hunter, A L & C D Klaassen. (1972). Species Difference in the Plasma Disappearance and Biliary Excretion of Procaine Amide Ethobromide. Experimental Biology and Medicine. 139(4). 1445–1450. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact